ETS1 and breast cancer: Further in Suk-Chul Bae's datasets [29], the BC patients with high expression of GATA4 and ETS1 significantly displayed shorter lifespan than patients with low expression (P = 0.0049 for GATA4 and P = 0.0002 for ETS1) (Figure 3F).